Lei Lin

Lei Lin is a Postdoctoral Fellow at Rensselaer Polytechnic Institute (RPI) in Troy, New York, affiliated with The Linhardt Research Labs within the Center for Biotechnology and Interdisciplinary Studies (CBIS). CBIS serves as RPI's premier hub for cross-disciplinary research integrating engineering, life sciences, and medicine to address complex biological challenges.

Education:

• Ph.D. in Analytical Chemistry, Tsinghua University (2014)
• B.S. in Chemistry, Beijing Normal University (2009)

Dr. Lin specializes in developing advanced analytical methodologies using liquid chromatography-tandem mass spectrometry (LC-MS/MS) for heparin characterization. This research bridges pharmaceutical chemistry and glycobiology, focusing on precise quality control of anticoagulant therapeutics through structural analysis of glycosaminoglycans. Current work emphasizes optimizing detection sensitivity and specificity for complex biomolecular interactions in drug development contexts.

Scientific Awards:

• National Scholarship for Graduate Students, Tsinghua University
• First Prize in Dow Scholarship, Tsinghua University

Dr. Lin operates within The Linhardt Research Labs under Professor Robert J. Linhardt's direction, contributing to the lab's internationally recognized glycomics initiative. The team pioneers analytical frameworks for carbohydrate-based drug discovery, with particular expertise in heparin biosynthesis, contamination detection, and structure-activity relationship modeling for next-generation anticoagulants.